Orexigen Therapeutics, Inc. (NASDAQ:OREX)

Orexigen, Advaxis Tumble into Tuesday’s 52-Week Low Club

Posted: March 13, 2018 at 4:04 pm
Last updated: January 12, 2020 2:27 am

March 13, 2018: Here are four stocks trading with heavy volume among 36 equities making new 52-week lows in Tuesday's session. On the NYSE decliners led advancers by about 3 ...
Read Full Story »

Anthera, Orexigen Submerge in Monday’s 52-Week Low Club

Posted: March 12, 2018 at 4:04 pm
Last updated: January 12, 2020 2:30 am

March 12, 2018: Here are four stocks trading with heavy volume among 39 equities making new 52-week lows in Monday's session. On the NYSE advancers led decliners by around 8 ...
Read Full Story »

Wednesday’s Top 5 Biopharma Movers

Posted: January 4, 2017 at 12:15 pm
Last updated: January 12, 2020 4:10 pm

Biotech and pharma companies were on the move Wednesday. A few made absolutely massive gains on the day, giving more credence to the Trump rally and positive sentiment for the health care ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Chipotle, Oracle, Orexigen, PulteGroup, Reynolds American, Valeant and More

Posted: March 16, 2016 at 9:05 am
Last updated: January 13, 2020 11:54 am

Stocks were directionless on Wednesday ahead of the Federal Reserve's decision on interest rates. With the Dow over 17,250 and the S&P 500 at 2,015, the markets are almost flat ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Huntington Bancshares, Nucor, Orexigen, SanDisk, Square, VIVUS and Many More

Posted: February 29, 2016 at 8:45 am
Last updated: January 13, 2020 12:35 pm

Stocks were indicated to open lower on Monday morning, but that is after two weeks of a rally. Is it possible that the trend of selling into every rally is ...
Read Full Story »
ThinkstockPhotos-529331537

Orexigen Therapeutics Receives $15 Million Milestone Payment

Posted: September 23, 2015 at 9:50 am

Orexigen Therapeutics Inc. (NASDAQ: OREX) made waves in the market early on Wednesday, despite the sell-off on Tuesday. The company announced receipt of the first of three potential $15 million ...
Read Full Story »
153576724

Are Problems at Orexigen Still Just Getting Started?

Posted: May 13, 2015 at 2:15 pm

Orexigen Therapeutics Inc. (NASDAQ: OREX) had to bite the bullet Tuesday when it announced that it would be terminating its cardiovascular outcomes study of the obesity drug Contrave. However, things ...
Read Full Story »
ten dollar bills

8 Analyst Stocks Under $10 With Huge Upside Targets

Posted: March 28, 2015 at 11:00 am

The last full week of March was choppy and took away most of the 2015 gains for the Dow and the S&P. Still, investors keep looking for value, and the ...
Read Full Story »
Biotechnology word cloud

Wells Fargo’s Top Biotech Stocks for 2015

Posted: January 7, 2015 at 2:51 pm
Last updated: January 10, 2015 9:49 am

Looking back at 2014, biotechs had a phenomenal year, and this looks to continue into 2015. The NYSE Arca Biotech index was up over 45% for 2014, and Wells Fargo ...
Read Full Story »
153576724

Is Orexigen Really Worth Over 50% More?

Posted: November 19, 2014 at 1:50 pm

Merrill Lynch has released an analyst report that sees more than 50% upside for Orexigen Therapeutics Inc. (NASDAQ: OREX). The top analyst on the call was Steve Byrne, and the general ...
Read Full Story »
research

Merrill Lynch’s 5 Destroyed Biotech Stocks With 100% or More Upside Potential

Posted: October 20, 2014 at 8:35 am

While Friday was a welcome relief for shell-shocked stock investors, much of the damage that has been inflicted since the start of the quarter is still weighing on some top ...
Read Full Story »
ten dollar bills

9 Analyst Stocks to Buy Under $10 With Massive Upside Potential

Posted: September 6, 2014 at 9:10 am

With stocks at or close to all-time highs, many investors are looking for new ideas and other stocks that may be lesser known than other big names. 24/7 Wall St. ...
Read Full Story »
biotech

Credit Suisse Positive on Some Biotechs, Very Cautious on Others

Posted: September 3, 2014 at 11:50 am

Credit Suisse has launched new biotech coverage on Wednesday with two analysts at the firm. The biotech sector has been a wealth-creation engine in recent years. What is interesting here ...
Read Full Story »
buy sell

Twelve Analyst Stocks Trading Under $10 With Huge Implied Upside

Posted: June 14, 2014 at 11:10 am

Stocks have pulled back from their all-time highs after escalation of civil war in Iraq, but Friday managed to close higher. Investors remain bullish, and they keep hearing that the ...
Read Full Story »
thumbs up

Three Analyst Stocks Projected to Double, or More

Posted: June 14, 2014 at 9:10 am

Every week at 24/7 Wall Street we see the research reports from many firms across Wall Street, and we are always sifting through the mounds of data looking for the ...
Read Full Story »